Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06612541 · ClinicalTrials.gov registry record
Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity
A clinical trial of Retinopathy of Prematurity (ROP) and ROP Examination, sponsored by Vanderbilt University Medical Center.
- Recruiting
- Registry status
- 90
- Enrollment target
- 1
- Study location
NCT06612541: Recruiting study of Retinopathy of Prematurity (ROP) and ROP Examination, sponsored by Vanderbilt University Medical Center.
NCT06612541 is a study of Retinopathy of Prematurity (ROP) and ROP Examination that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 90 participants, below the 2,529-participant average among 3 other Retinopathy of Prematurity (ROP) trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06612541, a study of Retinopathy of Prematurity (ROP) and ROP Examination, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.
- RECRUITING
- Registry status
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this proposal is to develop novel HH-SECTR technology for visualizing and quantifying diagnostic disease features in prematurely born infant retinopathy of prematurity (ROP) patients that lead to more informed clinical decision making. Providing depth-resolved vascular information has not been adequately investigated for its diagnostic potential. Furthermore, we seek to identify disease features not currently accessible by standard examination methods to better inform clinical decisions.
Primary Outcome
Real-time noninvasive optical imaging of the retina will be performed out to the ora serrata and ROP diagnostic markers will be evaluated in post-processing and compared against clinical examination
Conditions Studied
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2025-02-01 |
| Est. Completion | 2030-02 |
What NCT06612541 shows while recruiting
NCT06612541 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 2,529-participant average among 3 other Retinopathy of Prematurity (ROP) trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Retinopathy of Prematurity (ROP) appearing as the primary indexed condition, and to 0 interventions.
NCT06612541 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT06612541 about?
NCT06612541 is a clinical study titled "Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity". The goal of this proposal is to develop novel HH-SECTR technology for visualizing and quantifying diagnostic disease features in prematurely born infant retinopathy of prematurity (ROP) patients that lead to more informed clinical decision making. Providing depth-resolved vascular information has no...
What is the current status of trial NCT06612541?
This trial is currently recruiting. The enrollment target is 90 participants. The study started on 2025-02-01. Estimated completion is 2030-02.
What conditions does trial NCT06612541 study?
This clinical trial studies the following conditions: Retinopathy of Prematurity (ROP), ROP Examination.
Who is sponsoring clinical trial NCT06612541?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06612541 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retinopathy of Prematurity (ROP)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI